Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
No Data Available.
Synonyms :
xylometazoline
Class :
Drugs for asthma and COPD & Decongestant (Alpha-Adrenergic Agonist)
Adult:Â
Dosage forms & Strengths:Â
Nasal drops/sprayÂ
0.05%Â
Nasal CongestionÂ
>12 years:Â Â
Use 0.05% spray, put 2 to 3 drops or sprays in each nostril every 8 to 10 hoursÂ
Do not use more than 3 doses per dayÂ
Dosage forms & Strengths:Â
nasal drops/sprayÂ
0.05%Â
Nasal CongestionÂ
For 2-12 years old:Â Â
Use 0.05% spray, put 2 to 3 drops or sprays in each nostril every 8 to 10 hoursÂ
Do not exceed 3 doses in 24 hoursÂ
Refer adult dosingÂ
may increase the hypertension effect
it increases the toxicity of sympathomimetics
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the hypertension effect
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
combining proquazone and xylometazoline may raise the risk of hypertension
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
sympathomimetics increase the effect of hypertension of solriamfetol
it increases the effect of hypertension of sympathomimetics
it increases the arrhythmogenic effect of sympathomimetics
sympathomimetics increase the toxicity of doxofylline
it increases the effect of hypertension of sympathomimetics
may increase the hypertension effect
may increase the therapeutic effect
may enhance the adverse/toxic effect of sympathomimetics
may increase the tachycardic effect of cannabinoid-containing products
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may enhance the risk or severity of hypertension when combined
arrhythmogenic activity of agmatine may be enhanced with xylometazoline
prenylamine has the potential to enhance the arrhythmogenic activities of xylometazoline
the risk of hypertension may be increased
it increases the effect of hypertension of sympathomimetics
it increases the effect of hypertension of sympathomimetics
Nasal airflow resumes when α-adrenergic receptors are activated that causes the nasal mucosa’s blood vessels to constrict.Â
Xylometazoline improves nasal airflow volume and reduces nasal resistance during inspiration and expiration.Â
Through the vasoconstriction of the nasal mucosa, which houses the venous sinuses, and nasal decongestion, which permits breathing through the nose, oxymetazoline mediates this action.Â
Frequency defined:Â Â Â
>10%Â
Headache Â
1% to 10%Â
DizzinessÂ
NauseaÂ
PainÂ
Back painÂ
MyalgiaÂ
WeaknessÂ
Fever Â
<1%Â
EdemaÂ
ArthralgiaÂ
BruiseÂ
HepatitisÂ
Hepatic failureÂ
Insomnia  Â
NoneÂ
Contraindication:Â
HypersensitivityÂ
Narrow-angle glaucomaÂ
Rhinitis siccaÂ
Caution:Â
Never take more than the suggested amount.Â
This product should not be used for longer than three days.Â
Patient should be stopped if symptoms continue.Â
Pregnancy consideration: Limited Not recommended to be administered during pregnancy.Â
Lactation: Xylometazoline excretion in breast milk is not known. Â
Pregnancy category:Â
The sympathomimetic drug xylometazoline causes the nasal mucosa to contract. The median duration of subjective nasal congestion alleviation was approximately 1.7 minutes, and the subjective peak duration of treatment was 30 minutes in one trial that included participants with common cold-related nasal congestion.Â
Xylometazoline was shown to have antioxidant properties in early in vitro research, where it mediated hydroxyl radical scavenging activity and prevented microsomal lipid peroxidation.Â
Xylometazoline should not be taken orally. Only use in your nose. Keep away from your eyes and mouth as they could burn.Â
Spray till a fine mist appears before using for the first time.Â
Before using, blow your nose. Patient should tilt their head forward slightly while using.Â
Press down once to release the spray while inhaling through the nose.Â
When you have finished taking your dose, replace the cap.Â
Patient information leafletÂ
Generic Name: xylometazolineÂ
Why do we use xylometazoline? Â
Xylometazoline is used for the temporary relief of nasal congestion due to cold and hay fever.Â
It is indicated to treat nose stuffiness and runny nose.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
